Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial.

Gopanandan Parthasarathy, Yogish C Kudva, Phillip A Low, Michael Camilleri, Ananda Basu, Adil E Bharucha
Author Information
  1. Gopanandan Parthasarathy: Division of Gastroenterology and Hepatology, and.
  2. Yogish C Kudva: Division of Endocrinology, Department of Internal Medicine, and.
  3. Phillip A Low: Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905.
  4. Michael Camilleri: Division of Gastroenterology and Hepatology, and.
  5. Ananda Basu: Division of Endocrinology, Department of Internal Medicine, and.
  6. Adil E Bharucha: Division of Gastroenterology and Hepatology, and.

Abstract

Context: In type 1 diabetes (T1D), delayed gastric emptying (GE) may predispose to a mismatch between insulin delivery and glucose absorption. Previous studies evaluated, only partly, the relationship between delayed GE and postprandial, but not diurnal, glycemia.
Objective: To assess the relationship between GE disturbances and glycemic control in T1D and the effects of accelerating GE on glycemic control.
Design, Setting, and Participants: This was a randomized placebo-controlled trial in 30 patients with T1D on an insulin pump at an academic medical center.
Intervention(s): GE was evaluated with a [13C]-Spirulina breath test at baseline (GEbaseline), during intravenous saline or erythromycin (2 or 3 mg/kg; GEiv), and after 7 days of oral erythromycin or placebo (GEoral). Weighed meals were provided throughout the study.
Main Outcome Measure(s): These were GE and continuous glucose monitoring (CGM).
Results: The baseline glycosylated hemoglobin was 7.6% ± 0.8% (60 ± 8.7 mmol/mol); 12 patients (40%) had delayed GE; faster GE was associated with a greater postprandial CGM-based glucose, but slower GE was not associated with postprandial hypoglycemia (<70 mg/dL). Intravenous (3 mg/kg) but not oral erythromycin accelerated GE. The relationship between GE and glycemia differed between the postprandial periods and the entire day. After adjusting for carbohydrate intake and insulin consumption, faster GE was associated with more hyperglycemia during the postprandial period but lower glucose values across the entire study.
Conclusions: In T1D, pharmacologically mediated acceleration of GE increases postprandial CGM-based glucose. In contrast, delayed GE is associated with greater CGM-based glucose values over the entire day.

Associated Data

ClinicalTrials.gov | NCT02755064

References

  1. Neurogastroenterol Motil. 2006 Jun;18(6):433-40 [PMID: 16700722]
  2. JAMA. 2016 Jan 26;315(4):407-8 [PMID: 26813213]
  3. Diabetes Care. 2013 Apr;36(4):810-6 [PMID: 23193216]
  4. Diabetes Care. 2007 Feb;30(2):263-9 [PMID: 17259492]
  5. Clin Gastroenterol Hepatol. 2016 Jul;14(7):929-36 [PMID: 26717862]
  6. J Clin Endocrinol Metab. 2015 Sep;100(9):3565-71 [PMID: 26171801]
  7. Diabetologia. 2006 Sep;49(9):2010-4 [PMID: 16832660]
  8. Exp Clin Endocrinol Diabetes. 2003 Aug;111(5):255-61 [PMID: 12951630]
  9. Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S45-54 [PMID: 19469677]
  10. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1453-1459.e4 [PMID: 23639598]
  11. Gastroenterology. 2015 Aug;149(2):330-9 [PMID: 25980755]
  12. Am J Gastroenterol. 1993 Feb;88(2):203-7 [PMID: 8424421]
  13. Diabetologia. 1990 Nov;33(11):675-80 [PMID: 2076799]
  14. Diabetes Care. 2015 Jun;38(6):1008-15 [PMID: 25998293]
  15. J Nucl Med. 1993 Apr;34(4):582-8 [PMID: 8455074]
  16. Am J Gastroenterol. 1999 Aug;94(8):2074-9 [PMID: 10445530]
  17. N Engl J Med. 2010 Jul 22;363(4):311-20 [PMID: 20587585]
  18. Nutrition. 1998 Oct;14(10):826-9 [PMID: 9785372]
  19. Neurogastroenterol Motil. 2013 Jan;25(1):e60-9 [PMID: 23216872]
  20. Gastroenterol Clin North Am. 2015 Mar;44(1):9-19 [PMID: 25667019]
  21. Am J Clin Nutr. 1988 Oct;48(4):1035-40 [PMID: 3048076]
  22. Diabetes Care. 1994 Aug;17(8):901-3 [PMID: 7956640]
  23. Diabetes Care. 2013 Apr;36(4):793-800 [PMID: 23172973]
  24. N Engl J Med. 1990 Apr 12;322(15):1028-31 [PMID: 2320062]
  25. Clin Gastroenterol Hepatol. 2008 Jun;6(6):635-643.e1 [PMID: 18406670]
  26. Neurogastroenterol Motil. 2011 Mar;23 (3):220-5, e113-4 [PMID: 21087356]
  27. Qual Life Res. 2004 Dec;13(10):1737-49 [PMID: 15651544]
  28. Diabetes Care. 1997 Jan;20(1):55-8 [PMID: 9028694]
  29. Diabetologia. 1993 Sep;36(9):857-62 [PMID: 8405758]
  30. Diabetes Care. 2008 Dec;31(12):2325-31 [PMID: 19033417]
  31. Diabetes Care. 2003 Mar;26(3):881-5 [PMID: 12610053]
  32. Eur J Radiol. 2014 Nov;83(11):2001-6 [PMID: 25217123]
  33. Clin Ther. 1994 Nov-Dec;16(6):989-99 [PMID: 7697695]
  34. Scand J Gastroenterol. 1999 Apr;34(4):396-403 [PMID: 10365900]
  35. Endocr Rev. 2010 Apr;31(2):171-82 [PMID: 19966012]
  36. Am J Gastroenterol. 2013 Jan;108(1):18-37; quiz 38 [PMID: 23147521]
  37. Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E494-502 [PMID: 25074985]
  38. Gastroenterology. 1995 Sep;109(3):755-65 [PMID: 7657103]
  39. Dig Dis Sci. 2003 Mar;48(3):488-97 [PMID: 12757160]
  40. J Clin Endocrinol Metab. 1999 Jul;84(7):2357-62 [PMID: 10404803]

Grants

  1. P01 DK068055/NIDDK NIH HHS

MeSH Term

Adult
Aged
Blood Glucose
Blood Glucose Self-Monitoring
Circadian Rhythm
Diabetes Mellitus, Type 1
Dietary Carbohydrates
Drug Administration Schedule
Erythromycin
Female
Gastric Emptying
Gastrointestinal Agents
Humans
Hypoglycemic Agents
Insulin
Male
Middle Aged
Young Adult

Chemicals

Blood Glucose
Dietary Carbohydrates
Gastrointestinal Agents
Hypoglycemic Agents
Insulin
Erythromycin

Word Cloud

Created with Highcharts 10.0.0GEglucosepostprandialT1Ddelayedassociatedinsulinrelationshiperythromycin7CGM-basedentire1evaluatedglycemiaglycemiccontrolpatientss:baseline3mg/kgoralstudy±fastergreaterdayvaluesContext:typediabetesgastricemptyingmaypredisposemismatchdeliveryabsorptionPreviousstudiespartlydiurnalObjective:assessdisturbanceseffectsacceleratingDesignSettingParticipants:randomizedplacebo-controlledtrial30pumpacademicmedicalcenterIntervention[13C]-SpirulinabreathtestGEbaselineintravenoussaline2GEivdaysplaceboGEoralWeighedmealsprovidedthroughoutMainOutcomeMeasurecontinuousmonitoringCGMResults:glycosylatedhemoglobin6%08%608mmol/mol1240%slowerhypoglycemia<70mg/dLIntravenousaccelerateddifferedperiodsadjustingcarbohydrateintakeconsumptionhyperglycemiaperiodloweracrossConclusions:pharmacologicallymediatedaccelerationincreasescontrastRelationshipGastricEmptyingDiurnalGlycemicControlTypeDiabetesMellitus:RandomizedTrial

Similar Articles

Cited By